Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Pamoic acid | 130-85-8 | 99.7% | 388.38 | 10 G
SDP

Catalog No. 5000451598
Encompass_Preferred

Pamoic acid (Embonic acid) is a potent GPR35 agonist with an EC50 of 79 nM. It exhibits neuroprotective and anti-inflammatory properties.

  • Potent GPR35 agonist with an EC50 of 79 nM.
  • Exhibits neuroprotective and anti-inflammatory properties.
  • Activates GPR35, which may increase the phosphorylation of ERK1/2, initiating an anti-inflammatory signal by suppressing NF-κB-dependent inflammatory genes.
  • Has neuroprotective activity in a mouse model of stroke, reducing infarct size in a GPR35 dependent manner.
  • Pamoic acid treatment results in a preferential increment of noninflammatory Ly-6CLo monocytes/macrophages in the ischemic brain along with reduced neutrophil counts.

Catalog No. 50-004-51598 Supplier Medchemexpress LLC Supplier No. HYW00861310G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pamoic acid (Embonic acid) is a potent GPR35 agonist with an EC50 of 79 nM. It exhibits neuroprotective and anti-inflammatory properties.

  • Potent GPR35 agonist with an EC50 of 79 nM.
  • Exhibits neuroprotective and anti-inflammatory properties.
  • Activates GPR35, which may increase the phosphorylation of ERK1/2, initiating an anti-inflammatory signal by suppressing NF-κB-dependent inflammatory genes.
  • Has neuroprotective activity in a mouse model of stroke, reducing infarct size in a GPR35 dependent manner.
  • Pamoic acid treatment results in a preferential increment of noninflammatory Ly-6CLo monocytes/macrophages in the ischemic brain along with reduced neutrophil counts.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.